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The present study was undertaken to test the chemopreventive eﬀects of one herbal medicinal plant, Indigofera aspalathoides,o n
chemically induced carcinogenesis in rats. A well-known polyaromatic hydrocarbon, namely, 20-methylcholanthrene, which is
a known carcinogenic substance, was used to induce ﬁbrosarcoma in Wistar strain of male albino rats. Fibrosarcoma rats were
treated with aqueous extracts of Indigofera aspalathoides. The rats were divided into four groups, each consisting of six animals.
GroupIservedasnormalcontrol,GroupIIservedasﬁbrosarcoma-inducedanimals,GroupIIIwereﬁbrosarcoma-bearinganimals
treated with aqueous extracts of Indigofera aspalathoides, and Group IV animals, which were normal healthy animals treated with
Indigofera aspalathoides aqueous extract, served as drug control set. Group III and Group IV animals were treated with aqueous
extract of Indigofera aspalathoides intraperitoneally at a dose of 250mg/kg. b.w. for 30 days. The ﬁbrosarcoma was proved by
pathological examinations. The activity levels of nucleic acids such as total DNA and RNA and hexose, hexosamine, and sialic acid
in liver and kidney of treated rats were used to monitor the chemopreventive role of the plant extract. The observed increase in the
levels of DNA, RNA, hexose, hexosamine, and sialic acid in liver and kidney tissues of ﬁbrosarcoma-bearing animals reached near
normal state after the treatment with aqueous extracts of Indigofera aspalathoides, suggesting that Indigofera aspalathoides does
have a chemotherapeutic role.
1.Introduction
Thediseasecancerwillbecometheleadingcauseofmortality
among human population [1]. Chemical carcinogenesis due
to a number of agents is a proven fact. Over 67% of cancers
are presently attributed to environmental factors of which
chemicals occupy a predominant proportion [2]. Consistent
evidence shows carcinogenesis to be caused by certain
chemicals such as polycyclic aromatic hydrocarbons (PAH)
like 20-methylcholanthrene or 3-methylcholanthrene. They
are readily detected in the air we breathe or the tobacco that
we smoke [3]. 20-Methylcholanthrene (20-MCA) causes a
wide range of tumors in all animal models.
The speciﬁc type of cancer produced varies with the
root of administration and include, tumors of the skin, soft
tissues, and breast. PAHs are metabolized by cytochrome
P450-dependentmixed-functionoxidasestogiveelectrophilic
epoxides. The epoxides either get detoxiﬁed or bind cova-
lently to the DNA. The resultant abnormal DNA induces
abnormalcelldivisionandproducemalignancy[3].20-MCA
has been extensively used as an eﬀective experimental model
in the ﬁeld of carcinogenesis.
Carcinogenesisisamultistagediseaseprocess.Theevents
leading to cancer is sequential, involving both intrinsic and
extrinsic factors. At the molecular level, cancer is caused by
abnormal gene expression. This occurs through a number
of mechanisms including a direct damage to DNA leading
to abnormal transcription of genome. Majority of chemical
carcinogens cause mutations presumably in critical genes
and alter the cell growth and diﬀerentiation through epi-
genetic factors. The development of fully malignant tumor2 ISRN Pharmacology
is to involve the activation of altered expression of proto-
oncogenestooncogenesandthelossorinactivationoftumor
suppression gene, the function of which is to control normal
cellular activity [4]. In the present study, 20-MCA was used
as a ﬁbrosarcoma inducing agent in rats. Fibrosarcoma is a
tumor composed of collagen ﬁbers forming mesenchymal
cells of ﬁbroblasts and they arise from subcutaneous ﬁbrous
tissues [5]. The tumor is a large, ﬁrm, and pale mass without
any capsule and inﬁltrates into the surrounding tissues. The
tumor occurs near ﬁbrous tissues and mostly in the region of
thigh and knee.
Most patients present with a solitary palpable mass
ranging from 3 to 8cm in the greatest dimension. The peak
age for ﬁbrosarcoma incidence is 30 to 55 years. Most studies
have reported a slightly higher incidence of this tumor in
men than in women [6]. Fibrosarcomas are assigned grades,
from 1 to 3, the higher grade sarcomas (grade 2 or 3) pose
a signiﬁcant threat and present problems in local control
[7]. Histological grading of ﬁbrosarcoma is mainly based on
the degree of cellularity, degree of cellular diﬀerentiation,
number of mitotic ﬁgures, the amount of collagen produced
by the tumor cells, and the extent of necrosis.
It is a fact that both surgery and radiotherapy may
fail to cure cancer chieﬂy because the tumors might have
already decimated to other parts of the body. For this reason,
chemotherapy is considered as one of the best alternative.
Chemotherapy, although being a major treatment
modality used in the control of advanced stages of malig-
nancies, exhibits severe toxicity on normal tissues [8]. Plant
products which have antioxidant and anticancer properties
could be considered as good chemopreventive agents. Recent
researches revolve around the urgency to evolve suitable
chemotherapy with less or no toxic side eﬀects.
Plants have played a major role in treatment of various
diseases of animals and humans since time immemorial.
More than 50% of all modern drugs are of natural origin and
many of which have the ability to control and cure cancer
[9]. A large number of active principles from traditional
medicinal plants have been reported to have chemopreven-
tive properties [10]. Most of the studies on chemoprevention
are based on individual chemicals with well-deﬁned mecha-
nisms. Since carcinogenesis is a multifactorial and multistage
process, the individual active compounds or active principles
may not always be eﬀective to control all the stages and,
therefore, it is of interest to investigate the chemopreventive
eﬀect of crude extracts of plants which might control
the diﬀerent stages of cancer etiology as compounds like
saponins, tannins, steroids, alkaloids present therein might
act holistically to eﬀect a proper cure for cancer.
The plant Indigofera aspalathoides is used as a potent
drug for many diseases in the traditional Indian system.
This plant belongs to the family Papilionaceae and it is
commonly known as Sivanar Vembu or Iraivanar Vembu
in Tamil language of India. The leaves, ﬂowers, and tender
shoots are said to be cooling and demulcent [11].This plant
is used for the treatment of leprosy, syphilis, and various skin
diseases [12]. The plant mainly contains saponins, tannins,
steroids, alkaloids, ﬂavonoids, and reducing sugars. The
present study was aimed at ﬁnding out the curative role of
the aqueous extract of Indigofera aspalathoides on 20-MCA-
induced ﬁbrosarcoma in rats. Some reports of its anticancer
and antioxidant properties are already been studied by us
[13–16]. The present study is to further know this plant’s
c h e m o p r e v e n t i v er o l eo ns o m em o r ep a r a m e t e r sl i k et o t a l
DNA and RNA content and on parameters like hexose,
hexosamine, and sialic acid.
2.MaterialsandMethods
2.1. Plant Materials. Resh aerial parts (leaves, stems, and
seeds)oftheplantIndigoferaaspalathoideswereobtainedand
authenticated by the Chief Botanist, Tamil Nadu Aromatic
and Medicinal Plants Corporation Limited (TAMPCOL)
at Government Siddha Medical College Campus, Arum-
bakkam, Chennai, India in 2001.
2.2. Preparation of Plant Extract. 1kg. of the shade dried
and coarsely powdered aerial parts of the plant Indigofera
aspalathoideswaschargedinanaspirationbottleandallowed
to soak in double distilled water for 48hrs at room temper-
ature. The extract was ﬁltered and concentrated on a water
bath. The inorganic material was precipitated and ﬁltered
oﬀ. The ﬁltrate was again concentrated in a China dish and
dried invacuum.Theyieldoftheextractwas10% w/wofthe
powdered aqueous extract.This wasstored in refrigeratorfor
further and future use.
2.3. Acute Toxicity Studies. Acute toxicity study of AEIA
(acute toxicity of Indigofera aspalathoides) was done as per
OECD guideline 425, using albino male rats. The animals
was kept fasting overnight providing only with water, after
which the extract was administered orally for one animal at
the limit dose of 2500mg kg−1 and observed for 14 days (
special attention for the ﬁrst 4hrs of administration followed
by the next 20hrs). In case of the death, the limit test
was terminated and main test was conducted. If the animal
survived, four additional animals were dosed sequentially so
that ﬁve animals could be tested. However, if three animals
died, the limit test was terminated and the main test was
performed. The LD50 is greater than 2500mg kg−1 if three or
moreanimalssurvived.Ifananimaldiedunexpectedlylatein
the study and there were other survivors, it was appropriate
to stop dosing and observing all animals to see if other
animals also die during a similar observation period.
2.4. Acute Toxicity Test. The AEIA has not shown any
mortality at the limit dose of 2500mg kg−1 body weight.
AEIA was found to be safe even at a higher concentration
and, based on this, the dose for the chemopreventive activity
was chosen.
2.5. Animals. Wistar strain male albino rats weighing 100 to
120g were obtained from TANUVAS-LAMU, Madhavaram,
Chennai, India. The animals were fed with normal pellet
diet (rat chew) and water ad libitum. The study protocol,ISRN Pharmacology 3
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Histopathological studies in liver of control and experimental animals (H & E 100x)
Group III ﬁbrosarcoma-bearing animals
   treated with Indigofera aspalthoides 
 showing mild congestion of sinusoids
   Group IV drug control animals 
treated with Indigofera aspalthoides 
    showing normal architecture
(b)
Figure 1: The histopathological patterns in liver before and after treatment.
Table 1: The levels of nucleic acids in liver and kidney of control and experimental animals.
Parameters
(mg/gm.wt. of tissue)
Group I
(control)
Group II
(ﬁbrosarcoma)
Group III
(ﬁbrosarcoma+ I.
aspalathoides)
Group IV I.
aspalathoides
Liver
DNA 5.45 ± 0.46 6.54 ± 0.25a∗ 5.46 ± 0.45aNSb∗ 5.32 ± 0.34aNS
RNA 7.58 ± 0.27 8.95 ± 0.45a∗ 7.72 ± 0.29aNSb∗ 4.38 ± 0.22aNS
Kidney
DNA 4.42 ± 2.1 5.90 ± 0.54a∗ 4.48 ± 0.29aNSb∗ 4.38 ± 0.22aNS
RNA 6.34 ± 0.38 7.99 ± 0.36a∗ 6.25 ± 0.41aNSb∗ 6.23 ± 0.42aNS
aGroup II, III, and IV compared with Group I, bGroup III compared with Group II. Values are mean ± SD: N = 6, ∗p<0.001, @p<0.05. NS: not signiﬁcant.
approved by the Ministry of Social Justice and Empow-
erment, Government of India, was followed (Institutional
Animals Ethics Committee (IAEC) no. 07/15/02).
2.6. Sample Collection. The animals were sacriﬁced by cervi-
cal decapitation at the end of the experimental period and
the liver and kidney were dissected out and known weight of
liver and kidney were homogenized in 0.1M Tris-HCl buﬀer
(pH-7.4). Animals were starved overnight before sacriﬁce.
2.7. Chemicals. All the chemicals and reagents used were
purchased from M/s. Sigma Chemicals, USA.
2.8. Induction of Fibrosarcoma. Fibrosarcoma was induced
in Wistar strain of male albino rats by subcutaneous
implantation of Millipore ﬁlter disc, impregnated with 5%
suspension of 20-MCA in paraﬃno i l[ 17]. Tumors which
appeared in about 4 weeks after implantation were highly
localized and were maintained by serial transplantation.4 ISRN Pharmacology
Histopathological studies in kidney of control and experimental animals (H & E 100x)
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Histopathological studies in kidney of control and experimental animals (H & E 100x)
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Figure 2: The histopathological patterns in kidney before and after treatment.
The tumor was minced and suspended in normal saline. A
suspension of about 1 × 106 cells in 0.5mL of saline was
injected subcutaneously, into the thigh. The transplanted
tumor became palpable in 4–6 days time.
2.8.1. Histopathological Analysis. The liver and kidney of
control and experimental animals were used for histopatho-
logical analysis. It was carried out in Department of Pathol-
ogy, Madras Medical College, Chennai, India. Figures 1 and
2 show the architecture of both liver and kidney, respectively,
before and after treatment on ﬁbrosarcoma-bearing animals
with Indigofera aspalathoides aqueous extract. From the
ﬁgures, it is clear that the treatment of this drug has restored
the liver and kidney architecture.
2.9. Experimental Design. The rats were divided into four
diﬀerentgroups,eachgroupconsisting ofsixanimals.Group
Ia n i m a l ss e r v e da sn o r m a lc o n t r o l ,G r o u pI Ia n i m a l s
were ﬁbrosarcoma-bearing animals after the incubation
period, Group III animals were ﬁbrosarcoma-bearing ani-
mals treated with aqueous extract of Indigofera aspalathoides
intraperitoneally at a dose of 250mg/kg b. w. for 30 days,
and Group IV animals which were administered with the
aqueous extract of Indigofera aspalathoides alone, at a dose of
250mg/kg b. w. for 30 days, served as drug control animals.
2.10. Tumor Measurements. Tumor measurements were
made using a vernier calipers, and tumor diameter (Td)
was calculated using the formula stated elsewhere. The
experiments were repeated twice
Td (cm)
=
Length of tumor (cm) + Width of tumor (cm)
2
(1)
2.11.StatisticalAnalysis. Thestatisticaldatawaspresentedas
the ± standard deviation (SD). One-way analysis of variance
(ANOVA), using SPSS 7.5 student version, was used for
statistical signiﬁcance between groups. The Tukey’s multiple
comparison method was used to compare the means of
diﬀerent groups and the signiﬁcance was denoted by P value.
2.12. Estimation of Nucleic Acids. A known amount of tissue
was homogenized in 5mL of ice cold distilled water using
a Portor Elvehjem homogenizer with a Teﬂon pestle. 5mL
of 5% trichloroacetic acid was added to the homogenateISRN Pharmacology 5
Table 2: The levels of hexose, hexosamine, and sialic acid in liver and kidney of control and experimental animals.
Parameters (mg/g.
defatted tissue)
Group I
Control
Group II
Fibrosarcoma
Group III
Fibrosarcoma + I.
aspalathoides
Group IV I.
aspalathoides
Liver: hexose 19.44 ± 1.84 31.89 ± 2.72a∗ 23.55 ± 2.12a@b∗ 20.91 ± 1.66aNS
Hexosamine 4.09 ± 0.36 8.86 ± 0.92a∗ 5.06 ± 0.46a∗b∗ 4.70 ± 0.32aNS
Sialic acid 0.28 ± 0.02 0.76 ± 0.08a∗ 0.35 ± 0.04a@b∗ 0.29 ± 0.03aNS
Kidney: hexose 18.84 ± 1.50 26.16 ± 3.05a∗ 20.18 ± 2.11a@b∗ 19.22 ± 1.75aNS
Hexosamine 2.17 ± 0.17 3.39 ± 0.38a∗ 2.62 ± 0.20a@b∗ 2.27 ± 0.16aNS
Sialic acid 0.30 ± 0.03 0.55 ± 0.07a∗ 0.36 ± 0.05aNSb∗ 0.32 ± 0.03aNS
aGroup II, III, and IV compared with Group I, bGroup III compared with Group II. Values are mean ± SD: N = 6, ∗p<0.001, @p<0.05, NS: not signiﬁcant.
and this was kept in ice for 30 minute to allow complete
precipitation of proteins. The mixture was centrifuged and
the precipitate obtained was washed thrice with ice cold 10%
TCA. Then it was treated with 95% ethanol to remove the
lipids.Theﬁnalprecipitatewasheatedat90◦Cfor15minutes
which facilitated the quantitative separation of nucleic acids
from proteins. The supernatant after centrifugation was used
for the estimation of DNA and RNA [18].
2.13. Estimation of DNA. The method of Burton 1956 [19]
was followed for DNA estimation. A known volume of
nucleic acid aliquot was made up to 3 mi with 1N perchloric
acid. This was mixed with 2mL of diphenylamine reagent.
This was kept in boiling water bath for 10 minutes and
the blue colour developed was recorded at 640nm in a
spectrophotometer. A reagent blank and standards were also
carried out. The values are expressed as mg/g wet tissue.
2.14. Estimation of RNA. The estimation was carried out by
the method of Rawal et al. 1977 [20]. Aliquot of nucleic acid
was made up to 2mL with 5% trichloroacetic acid. 3mL of
Orcinol-Ferric chloride reagent was added to this and mixed
well. The tubes were heated in a water bath for 20 minutes.
Reagent blanks and standards were also treated in the same
way. The tubes were cooled and the colour developed was
measured at 640nm using a spectrophotometer. The values
were expressed in mg/g wet tissue.
2.15. Estimation of Hexose and Hexosamine and Sialic Acid.
A known volume of delipidised tissue sample residue was
mixed with 2mL ethanol and left for 20 minutes and then
centrifuged. 3mL of 3N HCL was added to the precipitate
and hydrolysed for 4 hours at 100◦Ci naw a t e rb a t hf o r
the estimation of hexose and hexosamine by the method of
Folsch, 1951 [21].
2.16.EstimationofHexose. ThemethodofNiebes,1972[22],
was followed for estimating hexose. To 0.5mL of neutrilised
sample, 7mL Orcinol reagent was added very slowly to the
tubes keeping them in ice water bath. The contents were
m i x e dw e lla n dt h et u be sw e r eh e a t e da t8 0 ◦Cf o r1 5m i n u t e s .
After cooling the dark colour developed was read at 540nm
using a spectrophotometer. The standard consisted of 25 to
100µg of hexose and the blank containing 0.5mL of water
instead of the sample was also treated in the same way. The
Hexose content was expressed as mg/g of defatted tissue for
liver and kidney.
2.17. Estimation of Hexosamine. The level of Hexosamine
was assayed by the method of Wagner, 1979 [23]. 0.5mL
of the neutralized sample was made up to 1mL with water.
Standard galactosamine was made up to 1 mL. The blank
comprised of 1mL of water. 0.6mL of acetyl-acetone reagent
was added to all the tubes and heated in a boiling water
bath for 30 minutes. After cooling, 2mL of Ehrlich reagent
was added and the contents were shaken well. The pink
colour developed was read at 540nm against blank. The
Hexosamine content was expressed in mg/g of defatted
tissues of liver and kidney.
2.18. Estimation of Sialic Acid. The method of Warren, 1959
[24], was used to estimate sialic acid. A known amount of
delipidised residue of the tissue was hydrolysed with 1mL of
0.1N sulphuric acid at 80◦C for one hour. The hydrolysed
materials were neutralized and used for estimation of sialic
acid. To 0.5mL of neutralized sample, 0.25mL of Periodate
was added and incubated at 37◦C for 30 minutes. After
the incubation, the reaction was arrested by the addition of
0.25mL of Arsenite. The tubes were shaken well. 2mL of
TBA was added and the tubes were heated for 6 minutes in
water bath. 5mL of acidiﬁed butanol was added to the tubes
aftercoolingandshakenwell.Oncesettled,thebutanolphase
was separated. The absorbance for colour was read at 540nm
against a blank. Standard N-acetylneuraminic acid was also
treated similarly. Sialic acid content was expressed as mg/mL
of defatted tissue for liver and kidney.
3. Results and Discussion
Table 1 depicts the levels of nucleic acid, DNA, and RNA in
the liver and kidney of control and experimental animals.
Elevated levels of DNA and RNA were observed in Group
II animals as compared to normal control, Group I animals.
In the ﬁbrosarcoma-bearing Indigofera-aspalathoides-treated
Group III animals, the DNA and RNA levels reached near
normal levels. No signiﬁcant alteration occurred in the
values of DNA and RNA in Group IV animals which were
treated with the plant extract alone as compared with the6 ISRN Pharmacology
normal Group I animals. The lack of diﬀerence in the results
in Group IV and Group I normal control animals clearly
demonstrates that Indigofera aspalathoides extracts do not
have any toxic side eﬀects which justiﬁes the choice of
this drug. Nucleic acids play a vital role during neoplastic
transformation.
DNA and RNA contents were studied in order to
determine the eﬀects of Indigofera aspalathoides on macro-
molecular synthesis in ﬁbrosarcoma. It has been observed
that the tumor growth corresponds with the elevated levels
of DNA and RNA synthesis in the liver and kidney. The levels
of DNA and RNA progressively increased in ﬁbrosarcoma
animals.Amongthetwo,DNAincreasewasmuchprominent
compared to RNA content. But after the treatment with
Indigofera aspalathoides, there was a marked decrease in the
content of these two nucleic acids suggesting that the plant
extract might have controlled their biosynthesis indicating
the tumoricidal eﬀect during cancer therapy.
Table 2 depicts the levels of hexose, hexosamine, and
sialic acid in liver and kidney of control and experimental
animals. In Group II ﬁbrosarcoma-bearing animals, the
levels of these three parameters in liver and kidney tissues
were signiﬁcantly elevated (P<0.001) as compared to that
of the control group animals. But in Group III drug-treated
animals, these protein levels were reverted back to near
normal condition as compared with Group II ﬁbrosarcoma
animals. No signiﬁcant changes of these levels were observed
in Group IV drug-alone-treated animals when compared to
normal control group I animals.
Heidelberger, 1975 [25], has sited the reduced levels
of proteins in neoplastic tissues. The liver is an important
site of protein metabolism and it has the highest rate of
protein synthesis. Major protein mass of the organism is
severelyaﬀectedincancercachexia.Proteinwasteimpliesthe
underlying metabolic imbalance which is being expressed by
an elevation in the apparent protein degradation rate with
no change in the apparent synthesis rate [26]. Reduced liver
protein in Moris-hepatoma-bearing animals, in Walker 256
carcinoma, and in some other reports suggests increased
protein degradation [27] .T h e r ei sd e c r e a s ei nt h er e c y c l i n g
of amino acids in tumor conditions resulting in enhanced
eﬄux of these amino acids from the tissues. Thus the
host response to the tumor load results in tissue protein
breakdown. Treatment with Indigofera aspalathoides might
have prevented this protein breakdown thus bringing the
protein levels to near normal condition.
The crucial role of cell surface and cell membrane
constituents in neoplastic behaviours and the changes in
serum and tissue glycoconjugates have long been associated
with malignancies [28]. Abnormal increase in the level of
plasma protein components has been related to the changes
in hepatic cells during neoplastic transformation. Mecbeth
and Bakesi, 1994 [29], postulated that the presence of tumor
in hepatic cells induces the synthesis of glycoproteins, which
subsequentlyappearincirculation.Largeamountsofhexose,
hexosamnine, and sialic acids were reported in many cancer
conditions [30].
Sialic acid is acetylated derivative of neuraminic acid
and exists as terminal component of nonreducing end of
carbohydrate chains of glycoprotein. Levels of sialic acid can
be useful in early detection of cancer indicating progress of
the disease, degree of metastasis, and possible recurrence
[31]. Increased activity of sialyltransferase leads to an
increased expression of sialic acid in cancer conditions. The
inﬂuence of sialic acid on the oncogenicity of tumor cells has
been studied by many investigators as the main determinant
ofthecellsurfacenegativechargeelectromobilityandtheloss
ofcontactinhibition.Italsoactsasanantigen-maskingagent
and as component of cell surface involved in the adherence
of tumor cells to mesothelial membrane to form metastasis
[32]. The reversal of glycoprotein levels to almost normal
after the treatment of Indigofera aspalathoides may be due
to its potent antitumor activity. The plant extract may alter
cell membrane glycoprotein synthesis and structure. Thus
the aqueous extract of Indigofera aspalathoides shows strong
anticancer potency.
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